Ultrahuman M2 Live brings no-prescription glucose tracking to the US using Abbott’s Lingo CGM, with plans starting at $99 per ...

Ultrahuman has launched the new M2 Live glucose monitoring platform, which doesn't require a subscription and is cheaper than the M1 Live.

FiberSense’s device uses optical sensor technology to monitor the concentration of glucose in the subcutaneous tissue fluid.

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...

The Stelo Glucose Biosensor System uses a wearable sensor, paired with an application installed on a compatible smartphone or ...

Diabetes remains one of the nation’s most prevalent and dangerous chronic conditions, affecting nearly 15% of U.S. adults and causing more than 100,000 deaths each year. As a response, the landscape ...

Compare Apple Watch CGM apps for blood sugar readings, including Dexcom G7, FreeStyle Libre, and Eversense watch support.

Trinity Biotech's CGM+ trial confirmed accurate 15-day glucose tracking without finger-stick calibration. TRIB's redesigned sensor cuts disposable components, lowering cost compared to current CGM ...

FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE ...

The FDA has issued a class two device recall for Senseonics’ Eversense continuous glucose monitoring system. This posting follows a September notice from the company that alerted providers and ...

Continuous glucose monitoring (CGM)-derived metrics reliably identified cystic fibrosis-related diabetes in patients with cystic fibrosis. Additionally, a novel way of analysing CGM data called ...